Ticker Details
DexCom, Inc. DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
IPO Date:	April 14, 2005
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$28.13B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.71 | 2.04%
Avg Daily Range (30 D):	$1.02 | 1.47%
Avg Daily Range (90 D):	$0.92 | 1.40%

Institutional Daily Volume
Avg Daily Volume:	2.14M
Avg Daily Volume (30 D):	4.66M
Avg Daily Volume (90 D):	4.83M

Trade Size
Avg Trade Size (Sh.):	143
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	20,182
Avg Institutional Trade:	$7.21M
Avg Institutional Trade (30 D):	$8.41M
Avg Institutional Trade (90 D):	$6.95M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$24.31M
Avg Closing Trade (30 D):	$65.36M
Avg Closing Trade (90 D):	$53.23M
Avg Closing Volume:	356.91K

News

Feb 13, 2026 @ 6:48 PM Small Caps, Silver Rally As Inflation Cools Furthe... Source: Piero Cingari

Dec 26, 2025 @ 9:56 PM DexCom, Inc. Sued for Securities Law Violations â... Source: Levi & Korsinsky, Llp

Dec 26, 2025 @ 7:18 PM DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel &... Source: Bragar Eagel & Squire, P.C.

Dec 26, 2025 @ 2:00 PM DXCM Investors Have Opportunity to Lead DexCom, In... Source: The Schall Law Firm

Dec 23, 2025 @ 5:00 PM DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$2.14	$.69	$2.14
Diluted EPS	$2.09	$.67	$2.09
Revenue	$4.66B	$1.26B	$4.66B
Gross Profit	$2.8B	$792.7M	$2.8B
Net Income / Loss	$836.3M	$267.3M	$836.3M
Operating Income / Loss	$911.8M	$323M	$911.8M
Cost of Revenue	$1.86B	$466.9M	$1.86B
Net Cash Flow	$311.8M	$-917.8M	$311.8M
PE Ratio	34.97

Splits
Jun 13, 2022	4:1